康辰药业控股股东拟减持不超3%股份

Core Points - 康辰药业's controlling shareholder, Liu Jianhua, plans to reduce his stake in the company by up to 4.7807 million shares, which represents no more than 3% of the total shares [1] Summary by Category Shareholder Actions - Liu Jianhua intends to sell shares through centralized bidding and block trading methods within three months after a 15 trading day period from the announcement date, excluding any legally mandated holding periods [1]